Warning: The NCBI web site requires JavaScript to function. more...
Identification of potential therapeutic targets in human head & neck squamous cell carcinoma.
Han J, Kioi M, Chu WS, Kasperbauer JL, Strome SE, Puri RK.
Head Neck Oncol. 2009 Jul 14;1:27.
Related citations
Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma.
Gonzalez HE, Gujrati M, Frederick M, Henderson Y, Arumugam J, Spring PW, Mitsudo K, Kim HW, Clayman GL.
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):754-9.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis.
Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA, Reed SG.
Laryngoscope. 2000 Mar;110(3 Pt 1):374-81.
Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
Yoo GH, Piechocki MP, Ensley JF, Nguyen T, Oliver J, Meng H, Kewson D, Shibuya TY, Lonardo F, Tainsky MA.
Clin Cancer Res. 2002 Dec;8(12):3910-21.
Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.
Laryngoscope. 2004 Dec;114(12):2063-72.
Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma.
Li X, Nishida T, Noguchi A, Zheng Y, Takahashi H, Yang X, Masuda S, Takano Y.
J Cancer Res Clin Oncol. 2010 Oct;136(10):1573-83. Epub 2010 Feb 25.
Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM, Mithani SK, Liu C, Chang SS, Begum S, Dhara M, Westra W, Sidranksy D, Califano JA.
Arch Otolaryngol Head Neck Surg. 2009 May;135(5):487-95.
Differences in the expression of genes between normal tissue and squamous cell carcinomas of head and neck using cancer-related gene cDNA microarray.
Kainuma K, Katsuno S, Hashimoto S, Oguchi T, Suzuki N, Asamura K, Usami S.
Acta Otolaryngol. 2006 Sep;126(9):967-74.
Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF, Burk RD, Adrien L, Dunne A, Kawachi N, Sarta C, Chen Q, Brandwein-Gensler M, Prystowsky MB, Childs G, Smith RV, Belbin TJ.
J Pathol. 2007 Nov;213(3):283-93.
Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R, Witrkopf N, Trenkle T, Nitsch SM, Wollenberg B.
In Vivo. 2008 Jan-Feb;22(1):89-92.
Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
van Hal NL, van Dongen GA, Stigter-van Walsum M, Snow GB, Brakenhoff RH.
Int J Cancer. 1999 Sep 9;82(6):837-45.
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C.
Breast Cancer Res. 2008;10(3):R53. Epub 2008 Jun 17.
Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J, Guo X, Qian CN, Schoumans J, Leeser B, Kort E, Cole A, Resau J, Bradford C, Carey T, Wennerberg J, Anderson H, Tennvall J, Teh BT.
Clin Cancer Res. 2004 Dec 15;10(24):8204-13.
Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.
Hasina R, Whipple ME, Martin LE, Kuo WP, Ohno-Machado L, Lingen MW.
Lab Invest. 2008 Apr;88(4):342-53. Epub 2008 Feb 18.
DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L, Coates PJ, Gu X, Nylander K.
J Pathol. 2007 Dec;213(4):384-91.
Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS.
Clin Cancer Res. 2008 Feb 15;14(4):1002-14.
Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B.
Clin Cancer Res. 2005 Apr 1;11(7):2552-60.
Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis.
Leethanakul C, Knezevic V, Patel V, Amornphimoltham P, Gillespie J, Shillitoe EJ, Emko P, Park MH, Emmert-Buck MR, Strausberg RL, Krizman DB, Gutkind JS; Head and Neck Cancer Genome Anatomy Project.
Oral Oncol. 2003 Apr;39(3):248-58.
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE.
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8. Epub 2007 Jan 8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on